...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Good news thoughts

To me this is good news.

The science people have come through again in terms of starting a trial. Congrats to them. It was a nail bighter from my perspective.

  1. Now we need to have the trial successfully executed.
  2. Then we need successful results and moving to the next trial stage unless it somehow gets approval for treatmment at this stage. Then stage Eversana can do their thing.

Not to rain on the parade but the weakest link in the chain remains management. We now need management to step up and do their job.

  1. Pay out the debenture. Secure the IP. 
  2. Put RVX on a firm financial footing with funding for Covid and BoM2.
  3. Find a 3rd partner shareholder, BP or other, to balance the share distribution.
  4. Achieve this in a non-dilutive manner that reflects the true underlying value and potential of this science.

I will remain critical of management until I see a change in attitude that shows respect for retail shareholders.

BUT I'll be very happy if this trial succeeds.

We're off and running. GLTA

Toinv

Share
New Message
Please login to post a reply